STX — Shield Therapeutics Share News
0.000.00%
- £80.70m
- £92.79m
- $32.18m
- 25
- 12
- 99
- 38
REG - Shield Therapeutics - PDMR Transaction Notification
AnnouncementRCS - Shield Therapeutics - Abstract to be presented at Healthcare Conference
AnnouncementREG - Shield Therapeutics - Chief Financial Officer Transition
AnnouncementREG - Shield Therapeutics - Result of REX Retail Offer
AnnouncementREG - Shield Therapeutics - Completion of SWK Financing
AnnouncementREG - Shield Therapeutics - Block listing Interim Return
AnnouncementREG - Cavendish Financial - AGM Trading Statement
AnnouncementREG - Shield Therapeutics - Successful completion of US$6.1m Equity Fundraise
AnnouncementREG - Shield Therapeutics - $20m secured debt facility &proposed equity raise
AnnouncementREG - Shield Therapeutics - REX Retail Offer
AnnouncementREG - Shield Therapeutics - Interim results update and business update
AnnouncementREG - Shield Therapeutics - Notice of Results and Change in reporting currency
AnnouncementREG - Shield Therapeutics Jupiter Fund Mgmt - Holding(s) in Company
AnnouncementREG - Shield Therapeutics - Business Update and U.S. Q2 2023 Highlights
AnnouncementREG - Shield Therapeutics - Results of 2023 Annual General Meeting
AnnouncementREG - Peel Hunt LLP Shield Therapeutics - Form 8.5 (EPT/RI) - Shield Therapeutics Plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - AOP Health Intnl. Shield Therapeutics - Lapse of Offer
Announcement